Article Versions Notes

Moustafa M, Dähling K-K, Günther A, Riebandt L, Smit DJ, Riecken K, Schröder C, Zhuang R, Krech T, Kriegs M, et al. Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM⁺ and CD90⁺ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model. Cancers. 2022; 14(8):1882. https://doi.org/10.3390/cancers14081882

Moustafa, Mohamed, Katarzyna-Krystyna Dähling, Armin Günther, Leonie Riebandt, Daniel J. Smit, Kristoffer Riecken, Carina Schröder, Ruimeng Zhuang, Till Krech, Malte Kriegs, and et al. 2022. "Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM⁺ and CD90⁺ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model" Cancers 14, no. 8: 1882. https://doi.org/10.3390/cancers14081882

Moustafa, M., Dähling, K.-K., Günther, A., Riebandt, L., Smit, D. J., Riecken, K., Schröder, C., Zhuang, R., Krech, T., Kriegs, M., Fehse, B., Izbicki, J. R., Fischer, L., Nashan, B., Li, J., & Jücker, M. (2022). Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM⁺ and CD90⁺ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model. Cancers, 14(8), 1882. https://doi.org/10.3390/cancers14081882